Cestem Flavoured Tablets for Medium and Small Dogs

Summary of Product characteristics

                                Revised: October 2022
AN: 01546/2022
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
CESTEM Flavoured tablets for medium and small dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCES:
Febantel
........................................................................................150
mg
Pyrantel (as embonate)
..................................................................50
mg
Praziquantel
....................................................................................50
mg
EXCIPIENTS
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablets.
Yellow brown, oval, divisible tablet, with liver flavouring.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs (adults and puppies).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of mixed infections by adult cestodes and nematodes of the
following
species:
Nematodes:
Ascarids:
_Toxocara canis_, _Toxascaris leonina_ (adult and late immature
forms).
Hookworms: _Uncinaria stenocephala_, _Ancylostoma caninum_ (adults).
Whipworms: _Trichuris vulpis_ (adults).
Cestodes:
Tapeworms: _Echinococcus _spp., _Taenia _spp., _Dipylidium caninum_
(adult and immature
forms).
Revised: October 2022
AN: 01546/2022
Page 2 of 6
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substances or to
any of the
excipients.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Parasite
resistance
to
any
particular
class
of
anthelmintic
may
develop
following
frequent, repeated use of an anthelmintic of that class.
Fleas serve as intermediate hosts for one common type of tapeworm –
_ Dipylidium _
_caninum_. Tapeworm infestation may reoccur unless control of
intermediate hosts such
as fleas, mice etc is undertaken.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The product is not recommended for use in puppies of less than 3 kg
bodyweight.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMAL
                                
                                Read the complete document